carbon tetrachloride has been researched along with geranylgeranylacetone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ito, K; Machida, Y; Sugimoto, M | 1 |
Chen, B; Chen, J; He, W; Qi, L; Shao, D; Wang, L; Wang, M; Zhuang, Y | 1 |
Akazawa, Y; Ichikawa, T; Miuma, S; Miyaaki, H; Nakao, K; Sasaki, R; Senoo, T; Taura, N | 1 |
3 other study(ies) available for carbon tetrachloride and geranylgeranylacetone
Article | Year |
---|---|
Effects of ammonia solution on the gastric mucosa in cirrhotic rats and therapeutic effects of geranylgeranylacetone.
Topics: Ammonia; Animals; Anti-Ulcer Agents; Carbon Tetrachloride; Disease Models, Animal; Diterpenes; Gastric Mucosa; Hexosamines; Liver Cirrhosis, Experimental; Male; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1999 |
Geranylgeranylacetone attenuates hepatic fibrosis by increasing the expression of heat shock protein 70.
Topics: Actins; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Carbon Tetrachloride; Disease Models, Animal; Diterpenes; HSP70 Heat-Shock Proteins; Hydroxyproline; Liver; Liver Cirrhosis; Male; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Up-Regulation | 2015 |
Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice.
Topics: Animals; Apoptosis; Carbon Tetrachloride; Cell Count; Cell Line; Disease Models, Animal; Diterpenes; Endoplasmic Reticulum; Hep G2 Cells; Humans; Liver Cirrhosis, Experimental; Male; Mice, Inbred C57BL; Transcription Factor CHOP | 2018 |